Chiara De Luca Selected Research

Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance)

12/2021	Influence of the SOD2 A16V gene polymorphism on alterations of redox markers and erythrocyte membrane fatty acid profiles in patients with multiple chemical sensitivity.
3/2020	The SNP rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity.
1/2015	Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances.
1/2013	Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population.
1/2011	The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances.
11/2010	Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara De Luca Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 07/2012
6	Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance) 12/2021 - 11/2010
6	Inflammation (Inflammations) 01/2015 - 01/2003
4	Infections 01/2015 - 10/2008
3	Carcinogenesis 01/2015 - 01/2013
2	Persistent Infection 01/2015 - 12/2014
2	Neoplastic Cell Transformation 01/2015 - 12/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2010 - 03/2009
2	Necrosis 08/2009 - 04/2008
1	Syndactyly (Polysyndactyly) 01/2022
1	Phototoxic Dermatitis (Phototoxicity) 04/2018
1	Fibrosis (Cirrhosis) 01/2016
1	Periodontitis 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Chronic Periodontitis 01/2016
1	Obesity 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2013
1	Fibromyalgia (Fibrositis) 01/2013
1	Photosensitivity Disorders (Photodermatitis) 07/2012
1	Herpes Zoster 05/2012
1	Herpes Simplex 05/2012
1	Warts (Wart) 05/2012
1	Wounds and Injuries (Trauma) 02/2012
1	Medically Unexplained Symptoms 01/2011
1	Environmental Illness 01/2011
1	Vitiligo 09/2010
1	Breast Neoplasms (Breast Cancer) 04/2008
1	Colitis 01/2003
1	Ulcerative Colitis 01/2003

Drug/Important Bio-Agent (IBA)

10	AntioxidantsIBA 04/2018 - 01/2003
6	CytokinesIBA 03/2020 - 02/2010
6	PolyphenolsIBA 02/2012 - 04/2008
4	Free RadicalsIBA 04/2018 - 04/2008
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2011
4	Oxygen (Dioxygen)IBA 01/2015 - 01/2003
4	NitrogenIBA 01/2015 - 01/2003
3	Biological ProductsIBA 04/2018 - 11/2010
3	ResveratrolIBA 01/2013 - 02/2012
3	XenobioticsIBA 01/2013 - 11/2010
3	ChemokinesIBA 02/2012 - 08/2009
2	VitaminsIBA 01/2015 - 12/2014
2	MicronutrientsIBA 01/2015 - 12/2014
2	LipidsIBA 01/2015 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 09/2010
2	EnzymesIBA 01/2013 - 11/2010
2	UbiquinoneIBA 05/2012 - 03/2009
2	SeleniumIBA 05/2012 - 03/2009
2	Vitamin E FDA LinkGeneric 05/2012 - 03/2009
2	Rutin (Rutoside)IBA 02/2012 - 04/2008
2	acteosideIBA 02/2012 - 04/2008
2	QuercetinIBA 02/2012 - 04/2008
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Sunscreening Agents (Sunscreens)IBA 04/2018
1	Monoclonal AntibodiesIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	CollagenIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	NucleosidesIBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Retroelements (Retrotransposon)IBA 01/2016
1	efavirenz (Sustiva)FDA Link 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2015
1	Plant ExtractsIBA 07/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2012
1	Antiviral Agents (Antivirals)IBA 05/2012
1	Methionine (L-Methionine)FDA Link 05/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 05/2012
1	Superoxides (Superoxide)IBA 02/2012
1	polydatinIBA 02/2012
1	Protein Isoforms (Isoforms)IBA 09/2010
1	Messenger RNA (mRNA)IBA 09/2010
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2010
1	Glutathione (Reduced Glutathione)IBA 09/2010
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 09/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2010
1	CatalaseIBA 09/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010
1	Interleukin-4 (Interleukin 4)IBA 02/2010
1	N 30IBA 02/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	FlavonoidsIBA 04/2008
1	Dextran SulfateIBA 01/2003
1	Oxidants (Oxidizing Agents)IBA 01/2003
1	Chelating AgentsIBA 01/2003
1	ubiquinolIBA 01/2003
1	Peroxidase (Myeloperoxidase)IBA 01/2003

Therapy/Procedure

3	Chemoprevention 01/2015 - 07/2012
2	Therapeutics 01/2016 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2015 - 12/2014
1	Topical Administration 01/2016
1	Cryotherapy (Therapy, Cold) 05/2012
1	Secondary Prevention 05/2012